Lennar Cl A Common Stock (LEN) Holder Dreman Value Management Has Boosted Stake; As Amag Pharmaceuticals (AMAG) Shares Rose, Employees Retirement System Of Texas Boosted by $360,000 Its Position

August 10, 2018 - By Estela Ashley

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Logo

Dreman Value Management Llc increased its stake in Lennar Corp Cl A Common Stock (LEN) by 1291.68% based on its latest 2018Q1 regulatory filing with the SEC. Dreman Value Management Llc bought 7,453 shares as the company’s stock declined 10.19% with the market. The hedge fund held 8,030 shares of the homebuilding company at the end of 2018Q1, valued at $473,000, up from 577 at the end of the previous reported quarter. Dreman Value Management Llc who had been investing in Lennar Corp Cl A Common Stock for a number of months, seems to be bullish on the $17.26B market cap company. The stock increased 0.34% or $0.18 during the last trading session, reaching $53.45. About 2.10M shares traded. Lennar Corporation (NYSE:LEN) has risen 5.00% since August 10, 2017 and is uptrending. It has underperformed by 7.57% the S&P500. Some Historical LEN News: 27/03/2018 – Lennar Corporation’s First Quarter Earnings Conference Call to be Broadcast Live on the Internet; 12/04/2018 – Lennar: Jon Jaffe Has Been Elected as the New President, Also Named to Board; 12/04/2018 – LENNAR’S BOARD OF DIRECTORS ELECTS NEW EXECUTIVE POSITIONS; 22/04/2018 – DJ Lennar Corporation Class B, Inst Holders, 1Q 2018 (LEN.B); 04/04/2018 – Lennar 1Q-End Homebuilding Cash, Cash Equivalents $734M; 04/04/2018 – Lennar 1Q EPS 53c; 04/04/2018 – Lennar 1Q Net $136.2M; 23/05/2018 – Lennar also offers 90 days of Amazon tech services with the purchase of one of its new smart homes; 12/04/2018 – LENNAR CORP – JON JAFFE HAS BEEN ELECTED AS NEW PRESIDENT OF LENNAR; 12/04/2018 – LENNAR CORP – ELECTED BRUCE GROSS AS NEW CHIEF EXECUTIVE OFFICER OF LENNAR FINANCIAL SERVICES

Employees Retirement System Of Texas increased its stake in Amag Pharmaceuticals Inc (AMAG) by 37.5% based on its latest 2018Q1 regulatory filing with the SEC. Employees Retirement System Of Texas bought 18,000 shares as the company’s stock rose 19.10% while stock markets declined. The institutional investor held 66,000 shares of the health care company at the end of 2018Q1, valued at $1.33M, up from 48,000 at the end of the previous reported quarter. Employees Retirement System Of Texas who had been investing in Amag Pharmaceuticals Inc for a number of months, seems to be bullish on the $875.61M market cap company. The stock increased 0.79% or $0.2 during the last trading session, reaching $25.4. About 485,006 shares traded. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has risen 30.22% since August 10, 2017 and is uptrending. It has outperformed by 17.65% the S&P500. Some Historical AMAG News: 09/05/2018 – AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopa; 03/05/2018 – AMAG PHARMACEUTICALS – SEES 2018 TOTAL REVENUE $540 MLN – $580 MLN; 26/03/2018 – AMAG PHARMACEUTICALS SUBMITS A NDA TO U.S. FDA FOR BREMELANOTID; 04/05/2018 – LSV Asset Management Exits Position in Amag Pharma; 23/03/2018 – AMAG Pharmaceuticals: Sandoz Will Pay a Royalty on Sales of Generic Version of Feraheme to AMAG; 03/05/2018 – AMAG PHARMACEUTICALS – SEES 2018 NON-GAAP ADJUSTED EBITDA $120 MLN – $140 MLN; 23/03/2018 – AMAG Pharmaceuticals: If Sandoz Receives FDA Approval By a Certain Date, Sandoz May Launch its Generic Version of Feraheme on July 15, 2021; 03/05/2018 – AMAG PHARMA SEES FY REV. $540M TO $580M, EST. $541.8M; 22/03/2018 – Amag Pharma Forms Golden Cross: Technicals; 03/04/2018 – AMAG Technology Announces Symmetry Access Control V9

Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. AMAG Pharmaceuticals had 55 analyst reports since August 18, 2015 according to SRatingsIntel. The company was maintained on Wednesday, November 4 by Deutsche Bank. The firm has “Hold” rating given on Thursday, May 3 by Cantor Fitzgerald. Needham initiated the stock with “Buy” rating in Thursday, October 27 report. On Monday, June 4 the stock rating was maintained by Cantor Fitzgerald with “Hold”. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) earned “Hold” rating by Cantor Fitzgerald on Wednesday, February 14. The rating was maintained by Piper Jaffray with “Hold” on Wednesday, February 14. On Thursday, February 15 the stock rating was maintained by Jefferies with “Buy”. The stock has “Mkt Perform” rating by Leerink Swann on Tuesday, January 10. Piper Jaffray maintained it with “Hold” rating and $15.0 target in Thursday, January 18 report. Cantor Fitzgerald maintained the shares of AMAG in report on Tuesday, February 27 with “Hold” rating.

Investors sentiment decreased to 0.84 in 2018 Q1. Its down 0.06, from 0.9 in 2017Q4. It fall, as 27 investors sold AMAG shares while 55 reduced holdings. 32 funds opened positions while 37 raised stakes. 37.48 million shares or 0.65% less from 37.72 million shares in 2017Q4 were reported. Wells Fargo & Company Mn reported 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Bridgeway Mgmt Inc, a Texas-based fund reported 46,900 shares. 9,457 were accumulated by Mason Street Advisors Llc. 1,049 are owned by Zurcher Kantonalbank (Zurich Cantonalbank). Massachusetts Fincl Svcs Ma has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). 65,600 are held by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management Corporation. Vanguard Gru Incorporated Inc has 3.29 million shares for 0% of their portfolio. Advisory Services Ltd Liability Co holds 54 shares or 0% of its portfolio. Sei has 0% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Envestnet Asset Mngmt holds 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 122 shares. Los Angeles Capital Management And Equity Rech invested in 0% or 15,012 shares. Tci Wealth Advsr owns 47 shares or 0% of their US portfolio. 29,581 are owned by Hbk Investments Limited Partnership. Lpl Financial Ltd Llc has invested 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Guggenheim Ltd Liability Company invested in 105,006 shares.

More important recent AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) news were published by: Benzinga.com which released: “California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform” on August 06, 2018, also Nasdaq.com published article titled: “AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry┬«”, Seekingalpha.com published: “AMAG Pharmaceuticals, Inc. (AMAG) CEO Bill Heiden on Q2 2018 Results – Earnings Call Transcript” on August 04, 2018. More interesting news about AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) was released by: Nasdaq.com and their article: “AMAG Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday …” with publication date: July 26, 2018.

Since February 23, 2018, it had 0 buys, and 2 selling transactions for $516,016 activity. Another trade for 20,000 shares valued at $500,000 was made by HEIDEN WILLIAM K on Monday, June 4.

Employees Retirement System Of Texas, which manages about $7.39 billion US Long portfolio, decreased its stake in Kimberly Clark Corp (NYSE:KMB) by 11,000 shares to 17,000 shares, valued at $1.87M in 2018Q1, according to the filing. It also reduced its holding in Federal Realty Invt Tr (NYSE:FRT) by 33,324 shares in the quarter, leaving it with 19,676 shares, and cut its stake in Mckesson Corp (NYSE:MCK).

Investors sentiment increased to 2.09 in 2018 Q1. Its up 0.84, from 1.25 in 2017Q4. It is positive, as 50 investors sold LEN shares while 100 reduced holdings. 92 funds opened positions while 221 raised stakes. 274.75 million shares or 32.49% more from 207.37 million shares in 2017Q4 were reported. Nomura Asset Mgmt Co Ltd, Japan-based fund reported 40,720 shares. Menta Capital Limited Liability Company reported 0.14% stake. First Washington owns 66,068 shares. Metropolitan Life accumulated 41,590 shares. Northwestern Mutual Wealth Mgmt Co holds 0% of its portfolio in Lennar Corporation (NYSE:LEN) for 783 shares. Premier Asset Mgmt Limited Liability has 3.2% invested in Lennar Corporation (NYSE:LEN) for 242,331 shares. Barnett & holds 0.24% or 7,863 shares. Manufacturers Life Insurance The reported 9.28M shares. State Board Of Administration Of Florida Retirement Systems owns 307,871 shares for 0.05% of their portfolio. Glenmede Company Na accumulated 0% or 2,846 shares. Synovus Fincl invested in 0.03% or 31,570 shares. Moreover, Rhumbline Advisers has 0.06% invested in Lennar Corporation (NYSE:LEN). Mitsubishi Ufj Tru Bk Corp holds 0.06% or 580,631 shares in its portfolio. Amica Pension Fund Board Of Trustees has invested 0.06% of its portfolio in Lennar Corporation (NYSE:LEN). Oregon Pub Employees Retirement Fund stated it has 26,946 shares or 0.02% of all its holdings.

Among 26 analysts covering Lennar (NYSE:LEN), 23 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Lennar had 78 analyst reports since September 22, 2015 according to SRatingsIntel. On Wednesday, March 30 the stock rating was maintained by Credit Suisse with “Neutral”. Wood maintained Lennar Corporation (NYSE:LEN) on Friday, April 7 with “Outperform” rating. The rating was maintained by Maxim Group on Wednesday, May 23 with “Buy”. The firm earned “Neutral” rating on Wednesday, September 21 by Citigroup. RBC Capital Markets maintained Lennar Corporation (NYSE:LEN) rating on Monday, October 30. RBC Capital Markets has “Buy” rating and $64.0 target. The rating was maintained by KeyBanc Capital Markets with “Hold” on Tuesday, August 22. As per Wednesday, June 21, the company rating was downgraded by Evercore. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Wednesday, March 21 report. As per Thursday, September 29, the company rating was initiated by Wells Fargo. Wedbush initiated it with “Neutral” rating and $46 target in Tuesday, September 20 report.

Since April 2, 2018, it had 0 insider purchases, and 10 sales for $8.41 million activity. $156,884 worth of Lennar Corporation (NYSE:LEN) shares were sold by OLIVERA ARMANDO J. Another trade for 20,000 shares valued at $1.04 million was sold by JAFFE JONATHAN M. On Friday, April 6 the insider Gilliam Theron I sold $131,565. On Friday, April 6 GERARD STEVEN L sold $157,450 worth of Lennar Corporation (NYSE:LEN) or 2,500 shares. BOLOTIN IRVING sold $131,565 worth of Lennar Corporation (NYSE:LEN) on Friday, April 6. On Friday, April 6 HUDSON SHERRILL W sold $157,450 worth of Lennar Corporation (NYSE:LEN) or 2,500 shares.

Dreman Value Management Llc, which manages about $2.21 billion and $220.58M US Long portfolio, decreased its stake in Amgen Inc Common Stock Usd.000 (NASDAQ:AMGN) by 5,819 shares to 230 shares, valued at $39,000 in 2018Q1, according to the filing.

Another recent and important Lennar Corporation (NYSE:LEN) news was published by Seekingalpha.com which published an article titled: “Making A Down Payment On Lennar” on July 16, 2018.

Lennar Corporation (NYSE:LEN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts